Skip to main content
. Author manuscript; available in PMC: 2022 Sep 1.
Published in final edited form as: J Comp Neurol. 2021 May 14;529(13):3292–3312. doi: 10.1002/cne.25169

Fig. 7.

Fig. 7.

Controls in a PV/SMI-32 preparation. (a) Section processed for dual-labeling but with the SMI-32 antibody omitted. Note only blue particulate BDHC labeling for PV is present (BLp). (b) Section processed for dual-labeling but with the PV antibody omitted. Note only diffuse brown DAB labeling for SMI-32 is present (Lvm). Scale bar = 25 μm for (a) and (b).